Literature DB >> 22512468

Selective thyromimetics using receptor and tissue selectivity approaches: prospects for dyslipidemia.

Amit A Joharapurkar1, Vipin V Dhote, Mukul R Jain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22512468     DOI: 10.1021/jm2004706

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

Review 1.  Environmental endocrine disruption of energy metabolism and cardiovascular risk.

Authors:  Andrew G Kirkley; Robert M Sargis
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

2.  Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome.

Authors:  C S Filgueira; E Nicolov; R L Hood; A Ballerini; J Garcia-Huidobro; J Z Lin; D Fraga; P Webb; O M Sabek; A O Gaber; K J Phillips; A Grattoni
Journal:  Int J Obes (Lond)       Date:  2016-07-27       Impact factor: 5.095

3.  Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa.

Authors:  Seiya Kitamura; Kelli L Hvorecny; Jun Niu; Bruce D Hammock; Dean R Madden; Christophe Morisseau
Journal:  J Med Chem       Date:  2016-05-04       Impact factor: 7.446

4.  (-) Arctigenin and (+) pinoresinol are antagonists of the human thyroid hormone receptor β.

Authors:  Ifedayo Victor Ogungbe; Rebecca A Crouch; Teresa Demeritte
Journal:  J Chem Inf Model       Date:  2014-11-13       Impact factor: 4.956

5.  Thyromimetics: What does the future hold?

Authors:  A G Unnikrishnan; Manash Baruah; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2012-12

6.  Thyroid Hormone Analogues: An Update.

Authors:  Riccardo Zucchi
Journal:  Thyroid       Date:  2020-04-07       Impact factor: 6.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.